Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: Study on a series of 82 tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 8, 1997, Pages 2559-2565

  Gicquel, Christine ^a   Raffin Sanson, Marie Laure ^b   Gaston, Véronique ^a   Bertagna, Xavier ^b   Plouin, Pierre François ^d   Schlumberger, Martin ^e   Louvel, Albert ^c   Luton, Jean Pierre ^b   Le Bouc, Yves ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b Clin Maladies Endocriniennes M   (France)

^c Serv de Pathologie Professionnelle   (France)

^d Université Paris Descartes   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B;

ADOLESCENT; ADRENAL CORTEX TUMOR; ADULT; AGED; ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 11P; CHROMOSOME ABERRATION; FEMALE; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOSAICISM; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BLOTTING, SOUTHERN; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 11; DNA METHYLATION; FEMALE; GENE DELETION; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; MOSAICISM; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0030840738     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.8.2559     Document Type: Article

References (52)

1. Freeman D. 1986 Steroid hormone-producing tumors in man. Endocr Rev. 7:204-220.
2. Weiss L. 1984 Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 8:163-169.
3. Lyons J, Landis C, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
4. Reincke M, Karl M, Travis W, Chrousos G. 1993 No evidence for oncogenic munitions in guanine nueleotide-binding proteins of human adrenocortical neoplasms. J Clin Endocrinol Metab. 77:1419-1422.
5. Reincke M, Karl M, Travis W, et al. 1994 p 53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies. J Clin Endocrinol Metab. 78:790-794.
6. Lin S, Lee Y, Tsai J. 1994 Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab. 78:483-491.
7. Gicquel C, Dib A, Bertagna X, Amselem S, Le Bouc Y. 1995 Oncogenic mutations of α Gi2 protein are not determinant for human adrenocortical tumourigenesis. Eur J Endocrinol. 333:166-172.
8. Dahia P, Grossman A. 1995 The molecular pathogenesis of adrenal tumours. Endocr Relat Cancer. 2:267-279.
9. Mesiano S, Mellon S, Jaffe R. 1993 Mitogenic action, regulation and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab. 76:968-476.
10. Van Dijk J, Tanswell A, Challis J. 1988 Insulin-like growth factor (IGF)-II and insulin, but not IGF-I, are mitogenic for fetal rat adrenal cells in vitro. Endocrinol. 119:509-516.
11. Voutilainen R, Miller W. 1988 Developmental and hormonal regulation of mRNAs for insulin-like growth factor II and steroidogenic enzymes in human fetal adrenals and gonads. DNA. 7:9-15.
12. Voutilainen R, Miller W. 1987 Coordinate tropic hormone regulation of mRNAs for insulin-like growth factor II and the cholesterol side-chain-oleavage enzyme, P450scc, in human steroidogenic tissues. Proc Natl Acad Sci USA. 84:1590-1594.
13. De Chiara T, Robertson E, Efstratiadis A. 1991 Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 64:844-859.
14. Ogawa O, Eccles M, Szeto J, et al. 1993 Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature. 362:744-751.
15. Rainier S, Johnson L, Dobry C, Ping A, Grundy P, Feinberg A. 1993 Relaxation of imprinted genes in human cancer. Nature. 362:747-749.
16. Ferguson-Smith A, Sasaki H, Cattanach B, Surani M. 1993 Parental-origin-specific epigenetic moditication of the mouse H19 gene. Nature. 362:751-755.
17. Zhang Y, Tycko B. 1992 Monoallelic expression of the human H19 gene. Nat Genet. 1:40-44.
18. Hatada I, Mukai T. 1995 Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet. 11:204-206.
19. Brannan C, Dees E, Ingram R, Tilghman S. 1990 The product of the H19 gene may function as an RNA. Mol Cell Biol. 10:28-36.
20. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. 1993 Tumour-suppressor activity of H19 RNA. Nature. 365:764-767.
21. Matsuoka S, Edwards M, Bai C, et al. 1995 p57 KIP2, a structurally distinct member of the p21CIP2 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
22. Gicquel C, Bertagna X, Schneid H, et al. 1994 Rearrangements at 11p15 locus and overexpression of Insulin like growth factor-II gene in sporadic adrenocorfical tumors. J Clin Endocrinol Metab. 78:1444-1453.
23. Gicquel C, Bertagna X, Le Bouc Y. 1995 Recent advances in the pathogenesis of adrenocortical tumours. Eur J Endocrinol. 133:133-144.
24. Coppes M, Haber D, Grundy P. 1994 Genetic events in the development of Wilms' tumor. N Engl J Med. 331:586-590.
25. Hastie N. 1994 The genetics of Wilms' tumor-a case of disrupted development. Annu Rev Genet. 28:523-558.
26. Moulton T, Crenshaw T, Hao Y, et al. 1994 Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet. 7:440-447.
27. Steenman M, Rainier S, Dobry C, Grundy P, Horon I, Feinberg A. 1994 Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat Genet. 7:433-439.
28. Leighton PA, Ingram R, Eggenschwiler J, Efstratiadis A, Tilghman S. 1945 Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature. 375:34-39.
29. Voutilainen R, Ilvesmaki V, Ariel I, Rachmilewitz J, De-Grott N, Hochberg A. 1994 Parallel regulation of parentally imprinted H19 and Insulin-like growth factor-II genes in cultured human fetal adrenal cells. J Clin Endocrinol Metab. 134:2051-2036.
30. Liu J, Kahri A, Heikkilä P, Ilvesmaki V, Voutilainen R. 1995 H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab. 80:492-496.
31. Ren-Qiu Q, Schmitt S, Ruelicke T, Stallmach T, Schoenle E. 1996 Autocrine regulation of growth by insulin-like growth factor (IGF)-II mediated by type 11CF-receptor in Wilms tumor cells. Pediatr Res. 39:160-165.
32. Christofori G, Naik P, Hanahan D. 1995 Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during β-cell tumor-igenesis. Nat Genet. 10:196-201.
33. Christofori G, Naik P, Hanahan D. 1994 A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature. 369:414-418.
34. El-Brady O, Romanus J, Helman L, Cooper M, Rechler M, Israel M. 1989 Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II. J Clin Invest. 84:829-839.
35. Vu T, Yballe C, Boonyanit S, Hoffman A. 1995 Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J Clin Endocrinol Metab. 80:1670-1676.
36. Susuki H, Ueda R, Takahashi T, Takahashi T. 1994 Altered imprinting in lung cancer. Nat Genet. 6:332-333.
37. van Gurp R, Oosterhuis J, Kalscheuer V, Mariman E, Looijenga L. 1994 Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst. 86:1070-1075.
38. Luton J, Cerdas S, Billaud L, et al. 1990 Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy. N Engl J Med. 322:1195-1201.
39. Weiss L, Medeiros J, Vickey A. 1989 Pathologic features of prognostic significance in adrenocortical carcinomas. Am J Surg Pathol. 13:202-206.
40. Le Bouc Y, Noguiez P, Sondermeijer F, Drover D, Girard F, Binoux M. 1987 A new 5′-non-coding region for human placental insulin-like growth factor II mRNA expression. FEBS Lett. 222:181-185.
41. Schneid H, Seurin D, Vazquez M, Gourmelen M, Cabrol S, Le Bouc Y. 1993 Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith-Wiedemann syndrome. J Med Genet. 30:353-362.
42. Tadokoro K, Fujii H, Inoue T, Yamada M. 1991 Polymerase chain reaction (PCK) for detection of Apa I polymorphism at the insulin like growth factor II gene (IGF 2). Nucleic Acids Res. 19:6967.
43. Myers T, Gelfand D. 1991 Reverse transcription and DNA amplification by a thermus thermophilus DNA polymerase. Biochemistry. 30:7661-7666.
44. Chao L, Huff V, Tomlinson G, Riccardi V, Strong L, Saunders G. 1993 Genetic mosaicism in normal tissues of Wilms' tumour patients. Nat Genet. 3:127-131.
45. Hough A, Hollifield J, Page D, Hartmann W. 1979 Prognostic factors in adrenal cortical tumors. Am J Clin Pathol. 72:790-799.
46. Marx C, Wolkersdörfer G, Brown J, Scherbaum W, Bornslein S. 1996 MHC class II expression-a new tool to assess dignity in adrenocortical tumours. J Clin Endocrinol Metab. 81:4488-4491.
47. Gicquel C, Leblond-Francillard M, Bertagna x, et al. 1994 Clonal analysis of human adrenocortical carcinomas and secreting-adenoivuis. Clin Endocrinol (Oxf). 40:465-477.
48. Beuschlein F, Reincke M, Karl M, et al. 1994 Clonal composition of human adrenocortical neoplasms. Cancer Res. 54:4927-4932.
49. Baylin S, Makos M, Wu J, et al. 1991 Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells (Cold Spring Harbor). 3:383-390.
50. Leighton P, Saam J, Ingram R, Stewart C, Tilghman S. 1995 An enhancer deletion affects both H19 and IGF II expression. Genes Dev. 9:2079-2089.
51. Tremblay K, Saam J, Ingram R, Tilghman S, Bartolomei M. 1995 A paternal-specific methylation imprint marks the alleles of the mouse H19 gene. Nat Genet. 9:407-413.
52. Morison I, Becroft D, Taniguchi T, Woods C, Reeve A. 1996 Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nat Med. 2:311-316.